Alarum Technologies (NASDAQ:ALAR – Get Free Report) and Avalon GloboCare (NASDAQ:CHGA – Get Free Report) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends.
Earnings & Valuation
This table compares Alarum Technologies and Avalon GloboCare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alarum Technologies | $40.76 million | 0.39 | $960,000.00 | $0.16 | 13.38 |
| Avalon GloboCare | $1.26 million | 1.40 | -$18.26 million | ($13.80) | -0.13 |
Profitability
This table compares Alarum Technologies and Avalon GloboCare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alarum Technologies | 2.53% | 17.11% | 12.65% |
| Avalon GloboCare | N/A | N/A | -53.69% |
Analyst Ratings
This is a breakdown of recent ratings and target prices for Alarum Technologies and Avalon GloboCare, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alarum Technologies | 1 | 1 | 1 | 0 | 2.00 |
| Avalon GloboCare | 1 | 0 | 0 | 0 | 1.00 |
Alarum Technologies presently has a consensus price target of $14.00, suggesting a potential upside of 554.21%. Given Alarum Technologies’ stronger consensus rating and higher probable upside, equities analysts clearly believe Alarum Technologies is more favorable than Avalon GloboCare.
Institutional and Insider Ownership
3.2% of Alarum Technologies shares are owned by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are owned by institutional investors. 2.7% of Alarum Technologies shares are owned by company insiders. Comparatively, 24.2% of Avalon GloboCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Alarum Technologies has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500.
Summary
Alarum Technologies beats Avalon GloboCare on 12 of the 14 factors compared between the two stocks.
About Alarum Technologies
Alarum Technologies Ltd. provides internet access and web data collection solutions in North, South, and Central America, Europe, Southeast Asia, the Middle East, and Africa. The company operates through two segments, Enterprise Internet Access Solutions and Consumer Internet Access Solutions. The company offers security blanket against ransomware, viruses, phishing, and other online threats, as well as secured and encrypted connection, masking the customers online activity and keeping them safe from hackers. It also provides privacy solutions and services, a software solution that uses an encryption protocol which is defined upon the process being used to generate a secured encrypted path and keep the users' data private and safe; and web data collection solution allows organizations to collect vast amounts of web and internet data by simultaneously connecting to the Internet from different IP addresses. In addition, the company offers static residential proxy network, rotating residential proxy network, data center proxy network, premium dedicated static residential proxies, mobile proxies, SERP data collection service, and social data collection service, as well as advertising services to enterprise customers. The company offers its products through resellers and internet service providers. It serves advertising and media companies, financial organizations, cyber security companies, industrial and commercial companies, online companies, education institutions, and AI recruitment market and other sectors. The company was formerly known as Safe-T Group Ltd. and changed its name to Alarum Technologies Ltd. in January 2023. Alarum Technologies Ltd. was founded in 2013 and is headquartered in Tel Aviv, Israel.
About Avalon GloboCare
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing mRNA-based Flash-CAR cell therapy platform. In addition, the company develops Avalon clinical-grade tissue-specific exosome (ACTEX); AVA-Trap, a therapeutic program provides an effective therapeutic option to combat COVID-19 and other life-threatening conditions involving cytokine storms; offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Avalon GloboCare Corp. has strategic partnership with HydroPeptide, LLC to engage in co-development and commercialization of a series of clinical-grade, exosome-based cosmeceutical, and orthopedic products; and corporate research agreement with the University of Pittsburgh of the Commonwealth System of Higher Education. The company was founded in 2016 and is headquartered in Freehold, New Jersey.
Receive News & Ratings for Alarum Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alarum Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
